Sonic Healthcare (OTCMKTS:SKHHY) Upgraded at Zacks Research

Sonic Healthcare (OTCMKTS:SKHHY – Get Free Report) was upgraded by analysts at Zacks Research from a “strong sell” rating to a “hold” rating in a research note issued to investors on Monday, Zacks reports.

Separately, The Goldman Sachs Group lowered Sonic Healthcare from a “buy” rating to a “hold” rating in a research report on Sunday, October 11th. Two research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Reduce”.

Check Out Our Latest Analysis on SKHHY

Sonic Healthcare Price Performance

Shares of OTCMKTS SKHHY opened at $13.08 on Monday. The firm has a fifty day moving average of $13.87 and a 200-day moving average of $14.15. Sonic Healthcare has a 52-week low of $12.58 and a 52-week high of $17.49.

About Sonic Healthcare

(Get Free Report)

Sonic Healthcare Limited is an Australian healthcare company specializing in medical diagnostics. Its principal business is laboratory medicine, providing pathology and clinical testing services used to diagnose, monitor and manage a broad range of medical conditions. The company serves hospitals, physicians, healthcare organizations and patients through networks of medical laboratories and collection centers.

Sonic Healthcare also operates medical imaging businesses in selected markets and provides related healthcare services, including occupational health and primary care offerings in Australia.

Recommended Stories

Receive News & Ratings for Sonic Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonic Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.